Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01463267 · ClinicalTrials.gov registry record · NA

Study of Reminding to Improve Medication Adherence in Heart Failure

A NA study of Heart Failure, sponsored by Kent State University.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT01463267 is a NA study of Heart Failure that has completed, run by Kent State University. The registered enrollment target is 60 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01463267, a NA study of Heart Failure, has completed, sponsored by Kent State University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study is being done to look at how people manage their heart failure. The investigators are testing two medication reminder systems and the investigators want to know which one people like better. The investigators also want to see if they have any effect on ease of managing medication in individuals with heart failure.

Conditions Studied

Interventions

  • DEVICE iPhone or pillbox
  • BEHAVIORAL Non-reminding

Study Locations (1)

Ohio

  • Akron City Hospital - Akron

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2010-11
Est. Completion 2012-09
Phase NA

Sponsor

Kent State University

19 total trials

What the Registry Record Tells You About NCT01463267

The ClinicalTrials.gov registry entry for NCT01463267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Kent State University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which iPhone or pillbox is the first listed.

NCT01463267 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01463267 about?

NCT01463267 is a clinical study titled "Study of Reminding to Improve Medication Adherence in Heart Failure". This study is being done to look at how people manage their heart failure. The investigators are testing two medication reminder systems and the investigators want to know which one people like better. The investigators also want to see if they have any effect on ease of managing medication in indiv...

What is the current status of trial NCT01463267?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-11. Estimated completion is 2012-09.

What conditions does trial NCT01463267 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT01463267?

The interventions under investigation include: iPhone or pillbox (DEVICE), Non-reminding (BEHAVIORAL).

Who is sponsoring clinical trial NCT01463267?

This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01463267 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.